Enhancement of therapeutic efficacy of Brinzolamide for Glaucoma by nanocrystallization and tyloxapol addition
The combination of BRI nanocrystallization and tyloxapol is expected to be highly effective in glaucoma treatment and a useful tool for new ophthalmic drug delivery.
Authors
- Noriaki Nagai (ORCID: https://orcid.org/0009-0007-1266-038X)
- Shuya Masuda
- Hiroko Otake
- Shiho Yano
- Tomohisa Tadokoro
Institutions
- Senju Pharmaceutical (Japan) (JP)
- Kindai University (JP)
Publication Details
- Journal
- Journal of Pharmaceutical Health Care and Sciences
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1186/s40780-024-00375-5
- Citations
- 5
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 2.69
Funders
- Japan Society for the Promotion of Science